USPTO serial 79344498
CARTISOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 2, 2024
- Examiner
- MANCA, ALBERTO I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CARTISOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
Patrick J. Concannon Nutter, McClennen & Fish, LLPSeaport West, 155 Seaport BoulevardBoston, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Lactose for medical purposes; cellular function activating agents for medical purposes; pharmaceutical preparations for the treatment of cells; drugs for medical purposes, namely, drugs being pharmaceutical preparations for medical purposes for the treatment and prevention of fibrotic disease, liver disease, liver fibrosis, liver diseases and conditions affecting function, arthritis, osteoarthritis, rheumatoid arthritis, joint pain, joint inflammation and inflammatory disease; pharmaceuticals, namely, pharmaceuticals for the treatment and prevention of fibrotic disease, liver disease, liver fibrosis, liver diseases and conditions affecting function, arthritis, osteoarthritis, rheumatoid arthritis, joint pain, joint inflammation and inflammatory disease; stem cells for medical purposes; therapeutic drugs and agents, namely, therapeutic drugs and agents being pharmaceuticals for the treatment and prevention of fibrotic disease, liver disease, liver fibrosis, liver diseases and conditions affecting function, arthritis, osteoarthritis, rheumatoid arthritis, joint pain, joint inflammation and inflammatory disease; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceutical preparations for therapeutic or medical purposes being nutraceuticals for the treatment and prevention of fibrotic disease, liver disease, liver fibrosis, liver diseases and conditions affecting function, arthritis, osteoarthritis, rheumatoid arthritis, joint pain, joint inflammation and inflammatory disease; bacterial preparations for medical and veterinary use; surgical implants comprising living tissue grown from stem cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 3, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 3, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 2, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 2, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 16, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 7, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 22, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 29, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 28, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 3, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 2, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 11, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |